Skip to main content
CXI Healthcare Technology Group Limited (KOSDAQ:900120)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,920.00
-15.00 (-0.51%)
At close: Nov 13, 2026

KOSDAQ:900120 Cash Flow Statement

Millions KRW. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
8,06712,74129,3497,5285,981
Depreciation & Amortization
30,39023,44224,64223,98025,713
Loss (Gain) From Sale of Assets
---3,823-509.09
Asset Writedown & Restructuring Costs
---153.75-
Loss (Gain) From Sale of Investments
-6,579-3,435-6,798--
Loss (Gain) on Equity Investments
160.64-315.15-295.04-224.74-
Stock-Based Compensation
1,299341.46--54.43660.98
Provision & Write-off of Bad Debts
-172.37-206.164.34--
Other Operating Activities
1,638489.361,070-631.65120.48
Change in Accounts Receivable
4,3287,605-623.676,2126,139
Change in Inventory
-105.4771.79170.951,145
Change in Accounts Payable
-779.15-441.0611.07-4,396-4,352
Change in Other Net Operating Assets
370.62-91.34-3.89-1,14167.31
Operating Cash Flow
38,72440,23643,66631,59735,984
Operating Cash Flow Growth
-3.76%-7.85%38.19%-12.19%312.50%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-231,829-55.92---5.78
Sale of Property, Plant & Equipment
--16,255--
Investment in Securities
----228.52-
Other Investing Activities
84.69190.13256.26202.93146.23
Investing Cash Flow
-231,738128.6216,511-25.3140.45

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
---234.78-
Long-Term Debt Issued
352.48365.9565.65326.24124.63
Total Debt Issued
352.48365.9565.65561.02124.63
Short-Term Debt Repaid
---204.26-45.33-
Long-Term Debt Repaid
-72.44-30.01-668.42-18.27-36.31
Total Debt Repaid
-72.44-30.01-872.67-63.6-36.31
Net Debt Issued (Repaid)
280.04335.94-807.03497.4288.33
Issuance of Common Stock
13,220981.17-961.721,072
Other Financing Activities
-12.88-4.041,060-2.73-4.87
Financing Cash Flow
13,4871,313252.811,4561,156

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-191.079.67-43.61-129.59-21.14
Miscellaneous Cash Flow Adjustments
-0--00
Net Cash Flow
-179,71841,68760,38632,89937,260

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-193,10640,18043,66631,59735,979
Free Cash Flow Growth
--7.98%38.19%-12.18%-
Free Cash Flow Margin
-390.31%69.71%62.90%44.12%35.49%
Free Cash Flow Per Share
-727191.61169209.43431465.9964418.6173350.61
Levered Free Cash Flow
-197,67737,92035,74129,69230,374
Unlevered Free Cash Flow
-197,67337,92235,74429,69430,407

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
7.684.045.242.734.87
Change in Working Capital
3,9207,178-544.69846.513,000